One-Sample Proportion Testing Procedures for Hypothesis of Inequality

REFERENCES

• Chow , S. , Shao , J. , Wang , H. ( 2003 ). Sample Size Calculation in Clinical Research. , 2nd ed. Boca Raton , FL : Chapman & Hall/CRC .
   Google Scholar
• Fleming , T. R. ( 1982 ). One sample multiple testing procedure for phase II clinical trials . Biometrics 38 : 143 – 151 .
   PubMed Web of Science ®Google Scholar
• Green , S. J. , Dahlberg , S. ( 1992 ). Planned versus attained designs in phase II clinical trials . Statistics in Medicine 11 : 853 – 862 .
   PubMed Web of Science ®Google Scholar
• Hong , S. , Wang , Y. ( 2007 ). A three-outcome design for randomized comparative phase II clinical trials . Statistics in Medicine 26 : 3525 – 3534 .
   PubMed Web of Science ®Google Scholar
• Palesch , Y. , Tilley , B. , Sackett , D. , Johnston , K. , Woolson , R. ( 2005 ). Applying a phase II futility design to therapeutic stroke trials . Stroke 36 : 2410 – 2414 .
   PubMedGoogle Scholar
• PASS. ( 2008 ). Software by NCSS LLC .
   Google Scholar
• Ravina , B. , Palesch , Y. ( 2007 ). The phase II futility clinical trial design . Progress in Neurotherapeutics and Neuropsychopharmacology 2 ( 1 ): 27 – 38 .
   Google Scholar
• Sargent , D. J. , Chan , V. ( 2001 ). A three-outcome design for phase II clinical trials . Controlled Clinical Trials 22 : 117 – 125 .
   PubMedGoogle Scholar
• Simon , R. ( 1989 ). Optimal two-stage designs for phase clinical trials . Controlled Clinical Trials 10 : 1 – 10 .
   PubMedGoogle Scholar
• Shuster , J. ( 2002 ). Optimal two-stage designs for single arm phase II cancer trials . Journal of Biopharmaceutical Statistics 12 ( 1 ): 39 – 51 .
   PubMedGoogle Scholar